Volume 32, Issue 12 (March 2022)
Studies in Medical Sciences 2022, 32(12): 919-926 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mahmoudzadeh H, Abbasi E, Nikibakhsh A A, Ghader S, Rasoli J. Comparison of the Effects of Potassium Polycitrate with No Treatment on Microlithiasis of the Infants Referred to a Pediatric Nephrology Clinic. Studies in Medical Sciences 2022; 32 (12) :919-926
URL: http://umj.umsu.ac.ir/article-1-5751-en.html
URL: http://umj.umsu.ac.ir/article-1-5751-en.html
Assistant Professor, Assistant Professor of Pediatric Neurology, Department of Pediatrics, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran (Corresponding Author) , Ezatolahabasi1353@gmail.com
Abstract: (3995 Views)
Background & Aims: Microlithiasis is a common increasing disorder, especially in infants and young children, defined as sonographic detection of hyperechogenic deposits in the pelvic area of the ureter and calyces which are less than 3 mm in diameter. Potassium citrate is one of the drugs used in nephrolithiasis. Citrate prevents the formation of calcium deposits. It also inhibits calcium oxalate crystals, which can be the nidus for kidney stones. The aim of this study was to compare the effect of potassium polycitrate versus no treatment in the infants with microlithiasis.
Materials & Methods: In this descriptive-retrospective study, 112 patients referred to a pediatric nephrology clinic were enrolled. Children less than two years old with microlithiasis in kidneys or urinary tract confirmed by ultrasonography imaging were included in the study. Patients were randomly divided into two groups: the first group received potassium citrate solution of 1-2 mEq/kg of body weight daily for two months, and the second group did not receive any specific medication. Follow-up was performed every two months for six months using ultrasound by a skilled radiologist with a fixed ultrasound device. To minimize drug side effects and treatment response, the allergic responses were measured once every two months, and the physician decided drug will or will not continue. Data analysis was done by SPSS 19. The P values <0.05 were considered significant.
Results: The mean age of the study population was 4.13 ± 2.27 months. The mean weight in the total study population was 6.62±1.36 kg and the mean birth weight in the total study population was 3±0.41 kg. According to the results of the study, the decrease in the size or number of stones in one or both kidneys was more in the recipients of polycitrate solution and the increase in the size or number of stones in one or both kidneys was more in the infants not receiving polycitrate (P<0.001).
Conclusions: Factors such as age, sex, current weight, birth weight and type of nutrition have no effect on improving and/or reducing the size and number of renal stones. However, in the group receiving potassium polycitrate solution, there was a significant reduction in the size and number of stones compared to the non-receiving group.
Materials & Methods: In this descriptive-retrospective study, 112 patients referred to a pediatric nephrology clinic were enrolled. Children less than two years old with microlithiasis in kidneys or urinary tract confirmed by ultrasonography imaging were included in the study. Patients were randomly divided into two groups: the first group received potassium citrate solution of 1-2 mEq/kg of body weight daily for two months, and the second group did not receive any specific medication. Follow-up was performed every two months for six months using ultrasound by a skilled radiologist with a fixed ultrasound device. To minimize drug side effects and treatment response, the allergic responses were measured once every two months, and the physician decided drug will or will not continue. Data analysis was done by SPSS 19. The P values <0.05 were considered significant.
Results: The mean age of the study population was 4.13 ± 2.27 months. The mean weight in the total study population was 6.62±1.36 kg and the mean birth weight in the total study population was 3±0.41 kg. According to the results of the study, the decrease in the size or number of stones in one or both kidneys was more in the recipients of polycitrate solution and the increase in the size or number of stones in one or both kidneys was more in the infants not receiving polycitrate (P<0.001).
Conclusions: Factors such as age, sex, current weight, birth weight and type of nutrition have no effect on improving and/or reducing the size and number of renal stones. However, in the group receiving potassium polycitrate solution, there was a significant reduction in the size and number of stones compared to the non-receiving group.
Type of Study: Research |
Subject:
کودکان (عمومی)
References
1. Polito C, Apicella A, Marte A, Signoriello G, La Manna A. Clinical presentation and metabolic features of overt and occult urolithiasis. Pediat Nephrol 2012;27(1):101-7. [DOI:10.1007/s00467-011-1940-8] [PMID]
2. La Manna A, Polito C, Cioce F, De Maria G, Capacchione A, Rocco CE, et al. Calyceal microlithiasis in children: report on 196 cases. Pediat Nephrol 1998;12(3):214-7. [DOI:10.1007/s004670050440] [PMID]
3. Polito C, La Manna A, Cioce F, Villani J, Nappi B, Di Toro R. Clinical presentation and natural course of idiopathic hypercalciuria in children. Pediat Nephrol 2000;15(3-4):211-4. [DOI:10.1007/s004670000433] [PMID]
4. Bilge I, Yilmaz A, Kayiran SM, Emre S, Kadioglu A, Yekeler E, et al. Clinical importance of renal calyceal microlithiasis in children. Pediat Int 2013;55(6):731-6. [DOI:10.1111/ped.12186] [PMID]
5. Matlaga BR, Schaeffer AJ, Novak TE, Trock BJ. Epidemiologic insights into pediatric kidney stone disease. Urol Res 2010;38(6):453-7. [DOI:10.1007/s00240-010-0327-9] [PMID]
6. Fallahzadeh MH, Zare J, Hosseini AHG, Derakhshan A, Basiratnia M, Arasteh MM, et al. Elevated serum levels of Vitamin D in infants with urolithiasis. Iran J Kidney Dis 2012;6(3):186-91. [Google Scholar]
7. VanDervoort K, Wiesen J, Frank R, Vento S, Crosby V, Chandra M, et al. Urolithiasis in pediatric patients: a single center study of incidence, clinical presentation and outcome. J Urol 2007;177(6):2300-5. [DOI:10.1016/j.juro.2007.02.002] [PMID]
8. van't Hoff WG. Aetiological factors in paediatric urolithiasis. Nephron Clin Pract 2004;98(2):c45-c8. [DOI:10.1159/000080251] [PMID]
9. Alpay H, Ozen A, Gokce I, Biyikli N. Clinical and metabolic features of urolithiasis and microlithiasis in children. Pediat Nephrol 2009;24(11):2203. [DOI:10.1007/s00467-009-1231-9] [PMID]
10. Mousavi Jazayeri SM, Pourmoghaddam A, Emam SJ. Microlithiasis and Nephrolithiasis among infants: Is it a new phenomenon?. Pakistan J Med Sci 2011;27(1). [URL]
11. Kelsoe J, Greenwood T, Akiskal H, Akiskal K. The genetic basis of affective temperament and the bipolar spectrum. Int Clin Psychopharmacol 2012;28:e5-e6. [DOI:10.1097/01.yic.0000423231.81230.9e]
12. Bartosh SM. Medical management of pediatric stone disease. Urologic Clin North America 2004;31(3):575-87. [DOI:10.1016/j.ucl.2004.04.005] [PMID]
13. Eshed I, Witzling M. The role of unenhanced helical CT in the evaluation of suspected renal colic and atypical abdominal pain in children. Pediatr Radiol 2002;32(3):205-8. [DOI:10.1007/s00247-001-0610-6] [PMID]
14. Malaki M. The comparison of ultrasound and non-contrast helical computerized tomography for children nephrolithiasis detection. Urology Annal 2014;6(4):309. [DOI:10.4103/0974-7796.140991] [PMID] [PMCID]
15. Polito C, Cioce F, La Manna A, Maiello R, Di Toro R. Renal calyceal microlithiasis: clinical presentation may precede sonographic evidence. Clin Pediatr 1999;38(9):521-4. [DOI:10.1177/000992289903800904] [PMID]
16. Spivacow FR, Negri AL, Polonsky A, Del Valle EE. Long-term treatment of renal lithiasis with potassium citrate. Urology 2010;76(6):1346-9. [DOI:10.1016/j.urology.2010.02.029] [PMID]
17. Barcelo P, Wuhl O, Servitge E, Rousaud A, Pak C. Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urology 1993;150(6):1761-4. [DOI:10.1016/S0022-5347(17)35888-3]
18. Ettinger B, Pak CY, Citron JT, Thomas C, Adams-Huet B, Vangessel A. Potassiummagnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urology 1997;158(6):2069-73. [DOI:10.1016/S0022-5347(01)68155-2]
19. Zmonarski S, Klinger M, Puziewicz-Zmonarska A, Krajewska M, Mazanowska O, Dembińska E. Therapeutic use of potassium citrate. Przeglad lekarski 2001;58(2):82. [Google Scholar]
20. Tekin A, Tekgul S, Atsu N, Bakkaloglu M, Kendi S. Oral potassium citrate treatment for idiopathic hypocitruria in children with calcium urolithiasis. J Urology 2002;168(6):2572-4.
https://doi.org/10.1016/S0022-5347(05)64218-8 [DOI:10.1097/00005392-200212000-00076]
21. Sorkhi H, Saeedizand N, Poornasrollah M, Bijani A, Shafi H. Efficacy of potassium polycitrate on renal stone and microlithiasis predisposed by metabolic disorders. Caspian J Inter Med 2017;8(4):296. [PMID] [PMCID]
22. Soygür T, Akbay A, Küpeli S. Effect of potassium citrate therapy on stone recurrence and residual fragments after shockwave lithotripsy in lower caliceal calcium oxalate urolithiasis: a randomized controlled trial. J Endourol 2002;16(3):149-52. [DOI:10.1089/089277902753716098] [PMID]
23. Reddy S, Shaik AB, Bokkisam S. Effect of potassium magnesium citrate and vitamin B-6 prophylaxis for recurrent and multiple calcium oxalate and phosphate urolithiasis. Korean J Urolog 2014;55(6):411-6. [DOI:10.4111/kju.2014.55.6.411] [PMID] [PMCID]
24. Güven AG, Koyun M, Baysal YE, Akman S, Alimoglu E, Akbas H, et al. Urolithiasis in the first year of life. Pediat Nephrol 2010;25(1):129. [DOI:10.1007/s00467-009-1296-5] [PMID]
25. Mokhless IA, Sakr MA, Abdeldaeim HM, Hashad MM. Radiolucent renal stones in children: combined use of shock wave lithotripsy and dissolution therapy. Urology 2009;73(4):772-5. [DOI:10.1016/j.urology.2008.10.066] [PMID]
26. Hosking DH, Erickson SB, Van Den Berg CJ, Wilson DM, Smith LH. The stone clinic effect in patients with idiopathic calcium urolithiasis. J Urology 1983;130(6):1115-8. [DOI:10.1016/S0022-5347(17)51711-5]
27. Mohammadjafari H, Kosaryan M, Tahernassab Z. Efficacy of Potassium Citrate in Treatment of Nephrolithiasis Less Than 7mm Diameter in Children without Any Metabolic or Infectious Risk Factors. J Mazandaran Univ Med Sci 2017;27(152):40-9. [Google Scholar]
28. Tasian GE, Copelovitch L. Evaluation and medical management of kidney stones in children. J Urology 2014;192(5):1329-36. [DOI:10.1016/j.juro.2014.04.108] [PMID]
29. Fallahzadeh MA, Hassanzadeh J, Fallahzadeh MH. What do we know about pediatric renal microlithiasis? J Renal Injury Prevent 2017;6(2):70. [DOI:10.15171/jrip.2017.13] [PMID] [PMCID]
30. Mohammadjafari H, Barzin M, Salehifar E, Kord MK, Aalaee A, Mohammadjafari R. Etiologic and epidemiologic pattern of urolithiasis in north iran; review of 10-year findings. Iranian J Pediat 2014;24(1):69. [PMID] [PMCID]
31. Stoller ML, Chi T, Eisner BH, Shami G, Gentle DL. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation. J Urology 2009;181(3):1140-4. [DOI:10.1016/j.juro.2008.11.020] [PMID]
32. Domrongkitchaiporn S, Stitchantrakul W, Kochakarn W. Causes of hypocitraturia in recurrent calcium stone formers: focusing on urinary potassium excretion. American J Kidney Dis 2006;48(4):546-54. [DOI:10.1053/j.ajkd.2006.06.008] [PMID]
33. Bozkurt HB, Çetin T, Sarıca K. The Possible Beneficial Effect of Breastfeeding on the Clinical Course of Urolithiasis Detected During Infancy. Breastfeed Med 2020;15(2):84-9. [DOI:10.1089/bfm.2019.0236] [PMID]
34. Elderwy AA, Kurkar A, Hussein A, Abozeid H, Hammodda HM, Ibraheim A-F. Dissolution therapy versus shock wave lithotripsy for radiolucent renal stones in children: a prospective study. J Urology 2014;191(5):1491-5 [DOI:10.1016/j.juro.2013.10.060] [PMID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
